Prognosis and Treatment of Metastatic Breast Cancer From A Real-World Scenario in China: A Retrospective Cohort Study.

Xie, Yuxin; Ma, Ji; Xia, Xueming; Zheng, Hong; Gou, Qiheng

Xie, Yuxin; Ma, Ji; Xia, Xueming; Zheng, Hong; Gou, Qiheng.

Affiliation

Xie Y; Department of Medical Oncology of Cancer Center, West China Hospital, 34753Sichuan University, Chengdu, China.
Ma J; Laboratory of Molecular Diagnosis of Cancer, Clinical Research Center for Breast, 34753West China Hospital, Sichuan University, Chengdu, China.
Xia X; Department of Medical Oncology, 34753West China Hospital, Sichuan University, Chengdu, China.
Zheng H; Department of Medical Oncology of Cancer Center, West China Hospital, 34753Sichuan University, Chengdu, China.
Gou Q; Department of Medical Oncology of Cancer Center, West China Hospital, 34753Sichuan University, Chengdu, China.

Cancer Control ; 29: 10732748221130568, 2022.

Article de En | MEDLINE | ID: mdl-36164749

Sujet(s)
Mots clés

metastatic breast cancer; overall response rate; prognostic factors; survival; systemic therapy mode

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans Langue: En Journal: Cancer Control Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google